Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage. - sprookjes - yvandenbroek - TriplyDB

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

http://www.wikidata.org/entity/Q34630073

about

Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial Antecedent glycemic control reduces severe hypoglycemia-induced neuronal damage in diabetic rats Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation Repeated Glucose Deprivation/Reperfusion Induced PC-12 Cell Death through the Involvement of FOXO Transcription Factor.Perioperative glucose control in neurosurgical patients.Altered Plasticity of Glycogen Phosphorylase in Forebrain Gliosomes Obtained from Insulinoma Patients.

P2860

Q34663582-F10A1FC2-28BD-43FB-8D7F-5D15FEEBBDE1 Q36923678-68CD11B1-9238-4CB3-B719-94DC7A029E3B Q37193301-D8850A3B-3B5B-42B5-BB1B-58F5306E7EBD Q41496608-5B5CB521-CA9E-4CAE-85B3-326EF58C6D8D Q41560664-A45FF606-A6CE-4BAB-85AD-1024E782BC88 Q48190896-C172704A-F1C0-4174-A108-F91E2148372C

P2860

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

http://www.wikidata.org/entity/Q34630073

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@ast

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@en

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@nl

type

label

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@ast

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@en

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@nl

prefLabel

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@ast

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@en

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@nl

P1433

Q34630073-8A81D6AD-408C-4CC0-ABCB-45E05E119354

P1476

Q34630073-FD619B32-BB21-4294-8904-48DE75647F31

P2093

Q34630073-25346F52-5656-45A0-9F96-FD4C2E60F21F

Q34630073-49BB641E-C514-44C7-B9E4-E42E45EC8247

Q34630073-938DBD5A-67C2-42DF-A768-51D9B071350F

Q34630073-94F9B12C-6DA8-44E6-A725-2662A36F0AA8

Q34630073-BAB80ED1-6D06-4152-A5D8-0EFD772352D1

Q34630073-C019F3D4-40FD-4BF0-986D-E794DA0FD690

P2860

Q34630073-024B40C2-BBA0-452A-9E0E-C8976104C480

Q34630073-0B042A25-90A7-45B9-A299-53411DAC5BF3

Q34630073-0D03D3EE-9B03-4073-8349-FE9E94EBA98C

Q34630073-0DDE786D-C021-4E9D-817F-F37456495B1A

Q34630073-12B3FEAC-CF27-4D2F-AD2A-EE07CBE979F1

Q34630073-19C34111-1675-40D7-BAB1-4A37AD3FD834

Q34630073-1AC18275-9762-421C-96AC-DAD6F8AEF0BA

Q34630073-2A588863-46A4-4B6E-8AA2-BFD36E946A22

Q34630073-2B683953-02BB-4357-B7F6-33F167DDA50D

Q34630073-35184B34-C9C6-4013-AB56-57B39F5C88E6

P304

Q34630073-903D3E86-FD30-49DC-A688-C4F000BA5C43

P31

Q34630073-70080AE5-9FFF-46F8-AE99-24E7FA726010

P356

Q34630073-56E5E432-694B-4278-84BB-5AE544EE5043

P407

Q34630073-F4ACA023-66B3-4A8A-B6DD-7F635841BB1C

P433

Q34630073-05846E48-02AF-41B3-BD86-F0DC9CE6894F

P478

Q34630073-4A871FE1-FFD6-4F21-8119-FE2CF515D59C

P577

Q34630073-7B263639-CDB4-4096-B843-B9E384703092

P5875

Q34630073-37918FEC-A782-4264-B1B9-91AFB9B22E95

P698

Q34630073-09B1F936-23B5-4AC0-832C-14BA03B82018

P921

Q34630073-7E1E999C-18F1-4813-B60A-659A5E36C4BE

P932

Q34630073-7FD3DC7C-4CF0-4E33-9ADB-506C5930AAF6

P356

J.NEULET.2011.01.045

P1433

Neuroscience Letters

P1476

Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

@en

P2093

Adam J Bree

http://www.w3.org/2001/XMLSchema#string

Daniel Musikantow

http://www.w3.org/2001/XMLSchema#string

Dorit Daphna-Iken

http://www.w3.org/2001/XMLSchema#string

Erwin C Puente

http://www.w3.org/2001/XMLSchema#string

Julie M Silverstein

http://www.w3.org/2001/XMLSchema#string

Simon J Fisher

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropsychological Profiles of Children With Type 1 Diabetes 6 Years After Disease Onset

The chemical biology of clinically tolerated NMDA receptor antagonists

Neuroprotective properties of memantine in differentin vitroandin vivomodels of excitotoxicity

Erythropoietin protects from post-traumatic edema in the rat brain.

Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data.

Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia.

Effects of anesthesia on functional activation of cerebral blood flow and metabolism.

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

In vivo evidence that erythropoietin protects neurons from ischemic damage.

Hypoglycemia, brain energetics, and hypoglycemic neuronal death.

P304

23-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NEULET.2011.01.045

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

492

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49790387

http://www.w3.org/2001/XMLSchema#string

P698

21272612

http://www.w3.org/2001/XMLSchema#string

P921

P932

3050002

http://www.w3.org/2001/XMLSchema#string